Related Experiment Videos
Efficient Cre/loxP site-specific recombination in a HepG2 human liver cell line
N Kobayashi1, H Noguchi, K A Westerman
1First Department of Surgery, Okayama University Medical School, Japan. ntanaka@med.okayama-u.ac.jp
Cell Transplantation
|January 6, 2001
Summary
Researchers developed a method to temporarily expand liver cells for transplantation by removing an oncogene. This technique uses Cre/loxP recombination, offering a potential solution to donor liver shortages in hepatocyte transplantation.
Area of Science:
- Hepatology
- Molecular Biology
- Gene Therapy
Background:
- Donor liver scarcity limits hepatocyte transplantation (HTX) clinical use.
- Reversible immortalization systems can expand primary hepatocyte populations.
- Oncogene transfer followed by excision is a potential strategy.
Purpose of the Study:
- To test the efficacy of Cre/loxP site-specific recombination for oncogene excision.
- To validate a reversible immortalization system for hepatocyte expansion.
- To address donor organ limitations in liver cell therapy.
Main Methods:
- Retroviral transfer of simian virus 40 large T antigen (SV40Tag) flanked by loxP sites.
- Adenovirus-mediated delivery of Cre recombinase (Ad-Cre).
- Assessment of oncogene elimination in HepG2 cells.
Main Results:
- Complete elimination of the retrovirally transferred SV40Tag oncogene was achieved.
- Site-specific recombination via Ad-Cre was effective in removing the immortalizing gene.
- Demonstrated feasibility of reversible oncogene expression in liver cells.
Conclusions:
- Cre/loxP recombination effectively excises oncogenes in liver cell lines.
- This system shows promise for temporary hepatocyte expansion.
- Potential to overcome donor liver limitations for HTX.